Study guide

Chronic Illness in Adolescence and Structured Healthcare Transition

EBP-EAP Examination in Paediatrics Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding

EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)

2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity

Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol

3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections

Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening

4 Chapter 4: Acute Paediatric Emergencies & Critical Care

EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination

5 Chapter 5: Paediatric Respiratory Medicine

Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations

6 Chapter 6: Paediatric Cardiology

Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever

7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition

Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure

8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance

Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management

9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism

Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)

10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health

Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy

11 Chapter 11: Paediatric Haematology & Oncology

Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia

12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy

Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules

13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions

The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia

14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics

Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics

15 Chapter 15: Paediatric Ophthalmology & ENT Disorders

Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions

16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health

Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance

17 Chapter 17: Adolescent Medicine & Healthcare Transition

Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition

18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics

Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics

19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine

Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy

Chronic Illness in Adolescence and Structured Healthcare Transition

Key Takeaways Explain This Topic AI

Chronic illness in adolescence (affecting 15–20% of European youth across conditions like cystic fibrosis, type 1 diabetes, congenital heart disease, epilepsy, sickle cell disease, and IBD) significantly impacts body image, self-esteem, peer integration, and developing autonomy.

Treatment non-adherence peaks during middle-to-late adolescence due to neurodevelopmental factors (striving for peer normalcy, discounting future consequences), complex therapeutic regimens, and parent-adolescent conflict; non-judgmental communication, digital tools, and gradual empowerment foster disease self-management.

Healthcare transition is fundamentally distinct from transfer: transition is an active, planned, multidimensional developmental process spanning several years (starting in early adolescence, no later than age 13–14), whereas transfer is the discrete operational handoff of care from paediatric to adult health services.

Structured transition guidance, including NICE NG43 and Ready Steady Go, supports a named coordinator, developmentally appropriate readiness review, gradual self-management, private consultation opportunities and coordinated contact with adult teams.

Uncoordinated or abrupt transfers carry severe risks of disengagement, clinic drop-out, preventable disease flares, graft failure in solid organ transplant recipients, and heightened adolescent-to-young-adult mortality.

Last updated: November 2026

Chronic Illness in Adolescence and Structured Healthcare Transition

Advances in paediatric therapeutics, surgery, and neonatal intensive care have transformed outcomes for childhood diseases: over 90% of children with chronic physical and neurodevelopmental conditions now survive into adult life . In Europe, an estimated 15% to 20% of adolescents live with a chronic illness or special healthcare need. Managing chronic disease during this developmental window requires balancing specialized disease control with the universal developmental imperatives of identity, peer integration, and emerging autonomy.

The Biopsychosocial Impact of Chronic Illness in Adolescence

A chronic medical condition—such as cystic fibrosis (CF), type 1 diabetes (T1D), congenital heart disease (CHD), epilepsy, sickle cell disease (SCD), or inflammatory bowel disease (IBD)—acts as a powerful disruptive stressor across every core developmental task. +--------------------------------------------------------------------------+

  • | INTERACTION: DEVELOPMENTAL TASKS VS CHRONIC ILLNESS BURDEN |
  • | |
  • | Universal Adolescent Task Disruption by Chronic Condition |
  • | ───────────────────────── ─────────────────────────────── |
  • | 1. Body Image & Somatic Identity --> Stomas, scars, pumps, delayed |
  • | puberty, cushingoid appearance |
  • | 2. Autonomy & Independence --> Enforced parental dependence, |
  • | infantilization, clinic vigilance |
  • | 3. Peer Integration & Normality --> School absence, dietary limits, |
  • | feeling 'different', stigma |
  • | 4. Vocational & Future Planning --> Career restrictions, insurance |
  • | barriers, fatigue, mortality fears|
  • +--------------------------------------------------------------------------+
  • Clinical Manifestations Across Developmental Domains

Body Image and Somatic Identity : Adolescence is characterized by acute bodily awareness. Visible indicators of illness—such as surgical scars (sternotomy in CHD, laparotomy in IBD), short stature and delayed puberty (celiac disease, CF, severe asthma), medication side effects (corticosteroid-induced cushingoid facies, hirsutism, gingival hyperplasia), or medical hardware (insulin infusion sets, continuous glucose monitors, ostomy bags)—provoke body dissatisfaction, perceived alienation, and shame.

Autonomy versus Dependency : While healthy adolescents gradually detach from parental oversight, chronic conditions enforce ongoing maternal and paternal involvement in daily therapies (e.g., administering injections, managing medications, performing airway clearance). This dynamic often induces parental overprotection ( 'infantilization' ) or, conversely, provocative adolescent rebellion where the patient rejects treatment as a means of asserting behavioral control.

Peer Integration and Stigma : The paramount social drive in middle adolescence is peer conformity. Fear of being rejected or labeled 'sick' leads adolescents to conceal conditions, skip doses when socializing, or participate in hazardous peer experimentation (e.g., binge drinking in diabetes or epilepsy) to prove normalcy.

Educational and Vocational Trajectories : Frequent clinic attendances, recurrent hospitalizations, chronic pain, and fatigue cause significant school absenteeism, threatening academic achievement, vocational qualification, and employment prospects.

Treatment Adherence Challenges and Self-Management Support

Treatment non-adherence peaks during middle-to-late adolescence, with documented non-adherence rates ranging between 30% and 70% across paediatric chronic conditions. Rather than interpreting non-adherence as irrational defiance, paediatricians must analyze its underlying neurodevelopmental and systemic drivers.

Drivers of Adolescent Non-Adherence

Neurodevelopmental Immaturity : The asynchronous brain development described by the dual-systems model leads adolescents to heavily discount delayed or probabilistic health risks (e.g., microvascular diabetic retinopathy or long-term allograft failure occurring 10 years later) while prioritizing immediate social rewards (avoiding peer embarrassment).

Regimen Burden and Complexity : Regimens requiring extensive daily time investment—such as cystic fibrosis therapies involving chest physiotherapy, hypertonic saline nebulizers, dornase alfa, oral pancreatic enzymes, and vitamin supplements taking > 2 hours >2\text{ hours} > 2 hours daily—frequently trigger treatment burnout.

Asymptomatic Disease States : When an illness is quiescent (e.g., well-controlled epilepsy, hypertension, or stable organ transplantation), adolescents perceive medications as an unnecessary nuisance offering no immediate symptomatic benefit.

Parent-Adolescent Conflict : Struggles over illness ownership transform medical regimens into battlegrounds for parental control.

Evidence-Based Strategies to Support Adherence +--------------------------------------------------------------------------+

  • | PILLARS OF ADOLESCENT ADHERENCE SUPPORT |
  • | |
  • | 1. Non-Judgmental Communication: Replace moralistic interrogation with |
  • | collaborative curiosity ('How many days a week is it tough to take?')|
  • | 2. Objective Self-Monitoring: Review CGM, smart inhaler, or pharmacy |
  • | refill data cooperatively without imposing disciplinary shame |
  • | 3. Regimen Simplification: Switch to once-daily dosing, fixed-dose |
  • | combinations, and sync dosing with daily habits (e.g., brushing) |
  • | 4. Triadic Role Re-negotiation: Guide parents to step back gradually |
  • | from 'micro-managers' to supportive 'consultants' |
  • | 5. Digital & Peer Platforms: Mobile apps, alarm reminders, and peer |
  • | mentorship programs providing normalization and shared experience |
  • +--------------------------------------------------------------------------+
  • Conceptual Distinction: Transition versus Transfer

In adolescent healthcare literature and European clinical governance, a fundamental distinction is maintained between transition and transfer .

Feature Healthcare Transition Healthcare Transfer

Definition A purposeful, planned, proactive, and multidimensional developmental process addressing the medical, psychosocial, and educational/vocational needs of adolescents as they move from child-centered to adult-oriented health systems. The discrete, event-based administrative and physical relocation of a patient's care from a paediatric service to an adult provider.

Temporal Dimension A multi-year continuum starting in early adolescence and extending into young adulthood; NICE advises planning by ages 13–14 at the latest. A single point in time, often occurring at an arbitrary institutional or legal boundary (e.g., the 18th birthday).

Focus & Objective Fostering self-management competencies, disease literacy, independent decision-making, and autonomous health navigation. Forwarding medical case notes, closing paediatric registration, and opening an adult clinic file.

Clinical Approach Holistic, youth-centered, multidisciplinary partnership involving adolescent, family, paediatric team, and adult team. Bureaucratic, system-oriented administrative discharge.

Caution

Conflating transfer with transition is a primary root cause of transitional failure. An abrupt transfer without longitudinal transitional preparation produces 'transfer shock,' high rates of clinic default, acute clinical decompensation, and preventable morbidity.

European Standards of Structured Transitional Care

The UEMS Multidisciplinary Joint Committee on Adolescent Medicine and Health addresses professional training. For the care pathway described here, NICE NG43 and the developers of Ready Steady Go provide practical guidance on planning, coordination, readiness and support across services.

The 'Ready Steady GO' Phased Framework

The Ready Steady Go framework uses approximate age bands, with progress adapted to the young person’s readiness and support needs: +--------------------------------------------------------------------------+

  • | THE READY STEADY GO FRAMEWORK |
  • | |
  • | [ READY ] (Around age 11): Foundation & Awareness |
  • | - Introduce the concept and long-term necessity of transition. |
  • | - Begin routine private consultation time alone with the adolescent. |
  • | - Establish basic knowledge: disease name, primary organs involved. |
  • | - Encourage adolescent to ask at least one question during visits. |
  • | │ |
  • | ▼ |
  • | [ STEADY ] (Around ages 13–14): Competence & Self-Management |
  • | - Teach practical skills: ordering pharmacy refills, booking visits. |
  • | - Master regimen details: medication names, exact doses, side effects. |
  • | - Discuss lifestyle impacts: alcohol, contraception, driving, careers. |
  • | - Address emergency plans: recognizing red-flag acute complications. |
  • | - Introduce adult clinic specialists or adult team nurse liaisons. |
  • | │ |
  • | ▼ |
  • | [ GO ] (From around age 16): Preparation for Transfer |
  • | - Conduct formal Transition Readiness Assessment (e.g., TRAQ). |
  • | - Finalize comprehensive written Transition Summary document. |
  • | - Build independent consultation skills; adapt family support to need. |
  • | - Attend joint / overlapping paediatric-adult transitional clinic. |
  • | - Execute formal transfer of care to adult service. |
  • | │ |
  • | ▼ |
  • | [ HELLO SERVICES ] (Post-Transfer Young Adulthood): Consolidation |
  • | - Adult clinic welcome appointment; verify attendance and retention. |
  • | - Audit for missed visits; activate safety-net re-engagement protocols.|
  • +--------------------------------------------------------------------------+
  • Core Structural Components of Effective Transition

The following care components support a structured pathway; apply them to the young person and service using NICE and programme guidance:

Early Initiation : Begin developmentally appropriate planning early, by 13–14 at the latest in NICE guidance. Ready Steady Go starts around 11; explain transition during stable care so it is not experienced as abandonment.

Designated Transition Key Worker / Coordinator : A designated clinical nurse specialist, youth worker, or adolescent physician acts as the continuous navigator across both services.

Private Consultation Opportunities : Offer time with the young person alone to develop confidence and discuss confidential concerns. Adapt its length and format to wishes, communication needs and capacity, while retaining appropriate family or carer support.

Objective Transition Readiness Assessment : Formal, validated instruments—such as the Transition Readiness Assessment Questionnaire (TRAQ) —measure functional competencies across five sub-domains: managing medications, keeping appointments, tracking health issues, managing daily activities, and communicating with healthcare providers.

Joint / Overlapping Paediatric and Adult Clinics : The adult specialist meets the adolescent and family within the familiar paediatric setting or during shared joint clinics, bridging institutional cultures and establishing immediate therapeutic rapport.

Standardized Comprehensive Transition Health Summary : A structured document authored by the paediatric team detailing the precise medical diagnosis, operative chronology, baseline organ function, current medication regimen, acute emergency protocols, psychosocial profile, and educational/vocational status.

Condition-Specific Transition Vulnerabilities and Failure Modes

Different chronic diseases face distinct pathophysiological and structural vulnerabilities during the transitional window:

Chronic Disease Primary Biological & Psychosocial Transition Vulnerabilities Manifestations of Transition Failure Targeted Transition Mitigation Strategies

Type 1 Diabetes Mellitus Shifting from parental glucose monitoring to solo management; alcohol-induced nocturnal hypoglycemia; body image issues leading to insulin omission for weight control ( 'diabulimia' ). Severe recurrent diabetic ketoacidosis (DKA), accelerated microvascular damage (retinopathy, microalbuminuria), high clinic drop-out rates. Dedicated young adult diabetes clinics, continuous glucose monitoring (CGM) sharing protocols, routine screening for eating disorders and depression.

Cystic Fibrosis Enormous daily treatment burden ( > 2 hrs/day >2\text{ hrs/day} > 2 hrs/day ); colonization with multi-resistant pathogens ( Pseudomonas aeruginosa , Burkholderia cepacia ); lung function decline; fertility concerns. Accelerated decline in forced expiratory volume in 1 second ( F E V 1 FEV_1 FE V 1 ​ ), frequent infective pulmonary exacerbations, severe nutritional failure. Transition key worker, strict segregation/infection control protocols during adult clinic tours, adult CF multidisciplinary orientation.

Congenital Heart Disease (ACHD) False perception of complete 'cure' following successful infantile corrective surgery; lack of awareness regarding late arrhythmias, conduit failure, or endocarditis risks. Heart failure, lethal ventricular arrhythmias, endocarditis, unintended high-risk pregnancy in women with severe Eisenmenger syndrome or aortic dilatation. Specialized Adult Congenital Heart Disease (ACHD) transition pathways, formal pregnancy/contraception counseling, personalized lesion-specific education.

Solid Organ Transplantation (Renal, Liver, Heart) High desire for peer conformity; feelings of invulnerability when feeling well; peer embarrassment regarding immunosuppressive side effects (gingival overgrowth, hirsutism). Acute and chronic allograft rejection, allograft loss, return to dialysis or death . Kidney-transplant registries identify late adolescence and early adulthood as a high-risk window; the relative increase depends on the comparator and transplant setting. Therapeutic drug monitoring, electronic adherence trackers, peer support mentors, strict 'safety-net' protocols tracking initial adult appointments.

Sickle Cell Disease Pain crises misjudged as 'drug-seeking' in adult emergency departments; lack of specialized adult hematologists; organ damage (renal, pulmonary hypertension). Acute chest syndrome, stroke, refractory vaso-occlusive crises, increased early-adult mortality after paediatric care , highlighting the need for continuous specialist access. Individualized emergency pain management passports, adult ED liaison protocols, hydroxyurea adherence counseling.

Inflammatory Bowel Disease (IBD) Cosmetic concerns over systemic corticosteroids; non-adherence to biologic maintenance infusions; alcohol, smoking, and dietary triggers. Disabling disease relapses, stricturing or penetrating complications, emergency bowel resections, impaired linear growth and bone density. IBD transition nurse specialist, objective non-invasive biomarker monitoring (fecal calprotectin), joint adolescent-adult endoscopy case conferences.